In this light and considering that CXCL10 seems involved in the early inflammatory signals in both myositis and in cardiomyopathy onset [26,27,28,29,31], we speculate that the inclusion of this chemokine within combined indexes of activity or response might be feasible and useful for evaluating/monitoring disease progression. Here, CXCL10 is linked to cardiomyopathy.